共 50 条
- [1] Real-world treatment patterns and clinical outcomes among patients with triple-class exposed (TCE) multiple myeloma (MM) [J]. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S177 - S178
- [2] Real-world clinical outcomes and treatment patterns among patients with triple-class exposed multiple myeloma: an analysis using the Connect® multiple myeloma disease registry [J]. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S193 - S194
- [3] The association between age, performance status, frailty and outcomes in real-world clinical practice among patients with triple-class exposed multiple myeloma [J]. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S173 - S173
- [5] Real-world treatment patterns and clinical outcomes in patients with triple-class exposed relapsed or refractory multiple myeloma in United States clinical practice [J]. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 : S165 - S166
- [6] The relationship of extramedullary disease and high-risk cytogenetics on real-world outcomes among patients with triple-class exposed multiple myeloma [J]. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S173 - S174
- [9] Variation in real-wolrd outcomes among patients with triple-class exposed mutliple myeloma across clinical subgroups: a German registry analysis [J]. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S174 - S174